Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,501,150
-
Share change
-
-1,516,605
-
Total reported value
-
$16,070,000
-
Put/Call ratio
-
694%
-
Price per share
-
$4.59
-
Number of holders
-
34
-
Value change
-
-$6,253,771
-
Number of buys
-
22
-
Number of sells
-
17
Institutional Holders of InflaRx N.V. - COM (IFRX) as of Q2 2020
As of 30 Jun 2020 InflaRx N.V. - COM (IFRX) had 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,501,150 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, ORBIMED ADVISORS LLC, MORGAN STANLEY, FNY Investment Advisers, LLC, Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, Verition Fund Management LLC, Birchview Capital, LP, and TWO SIGMA INVESTMENTS, LP.
This table shows 34 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.